Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 8173831 was granted and assigned to Catabasis Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office. | 8173831 | May 8, 2012 | |||||||
Patent 9708245 was granted and assigned to Catabasis Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office. | 9708245 | July 18, 2017 | |||||||
Patent 9029548 was granted and assigned to Catabasis Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office. | 9029548 | May 12, 2015 | |||||||
Patent 9278136 was granted and assigned to Catabasis Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office. | 9278136 | March 8, 2016 | |||||||
Patent 9272984 was granted and assigned to Catabasis Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office. | 9272984 | March 1, 2016 | |||||||
Patent 9289503 was granted and assigned to Catabasis Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office. | 9289503 | March 22, 2016 | |||||||
Patent 8729293 was granted and assigned to Catabasis Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office. | 8729293 | May 20, 2014 | |||||||
Patent 8946451 was granted and assigned to Catabasis Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office. | 8946451 | February 3, 2015 | |||||||
Patent 8969354 was granted and assigned to Catabasis Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office. | 8969354 | March 3, 2015 | |||||||
Patent RE46605 was granted and assigned to Catabasis Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office. | RE46605 | November 14, 2017 | |||||||
Patent 8940903 was granted and assigned to Catabasis Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office. | 8940903 | January 27, 2015 | |||||||
Patent 8735378 was granted and assigned to Catabasis Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office. | 8735378 | May 27, 2014 | |||||||
Patent RE46608 was granted and assigned to Catabasis Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office. | RE46608 | November 14, 2017 | |||||||
Patent RE45275 was granted and assigned to Catabasis Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office. | RE45275 | December 2, 2014 | |||||||
Patent 9084826 was granted and assigned to Catabasis Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office. | 9084826 | July 21, 2015 | |||||||
Patent 9458094 was granted and assigned to Catabasis Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office. | 9458094 | October 4, 2016 | |||||||
Patent 10251845 was granted and assigned to Catabasis Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office. | 10251845 | April 9, 2019 | |||||||
Patent RE45261 was granted and assigned to Catabasis Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office. | RE45261 | November 25, 2014 | |||||||
Patent 9238077 was granted and assigned to Catabasis Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office. | 9238077 | January 19, 2016 | |||||||
Patent 8765964 was granted and assigned to Catabasis Pharmaceuticals on July, 2014 by the United States Patent and Trademark Office. | 8765964 | July 1, 2014 | |||||||
Patent 9486534 was granted and assigned to Catabasis Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office. | 9486534 | November 8, 2016 | |||||||
Patent 9139516 was granted and assigned to Catabasis Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office. | 9139516 | September 22, 2015 | |||||||
Patent 9216224 was granted and assigned to Catabasis Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office. | 9216224 | December 22, 2015 | |||||||
Patent 8304551 was granted and assigned to Catabasis Pharmaceuticals on November, 2012 by the United States Patent and Trademark Office. | 8304551 | November 6, 2012 | |||||||
Patent 8735379 was granted and assigned to Catabasis Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office. | 8735379 | May 27, 2014 |